Skip to main content

New Products

  • FDA approves Mylan pulmonary arterial hypertension drug

    PITTSBURGH — The Food and Drug Administration has approved a generic drug made by Mylan for treating pulmonary arterial hypertension, the drug maker said Tuesday.

    Mylan announced the FDA approval of sildenafil citrate tablets in the 20-mg strength, a generic version of Pfizer's Revatio. The drug is used to treat adults with PAH to improve exercise ability and delay clinical worsening of the condition.

    Revatio had sales of about $339 million during the 12-month period ended in September, according to IMS Health.

  • Samuel Adams introduces 10th anniversary batch of barrel-aged Utopias beer

    BOSTON — Samuel Adams has once again stepped into the realm of "extreme beers" with its latest 10th anniversary release of Samuel Adams Utopias, the brewery's legendary barrel-aged beer. Aged to perfection — for some ingredients, 20 years — the new brew contains slightly more than 29% alcohol by volume, which compares with 5% ABV in Samuel Adams Boston Lager.

  • Ballantyne Brands advances share of electronic cigarette market

    CHARLOTTE, N.C. – Ballantyne Brands, an electronic cigarette provider, on Monday announced the introduction of a new premium brand, NEO. The company also announced that it has acquired the Mistic brand of electronic cigarettes for an undisclosed amount, and has secured an investment partner to support its business for the long term.

  • FDA approves new strength of HIV drug

    TITUSVILLE, N.J. — The Food and Drug Administration has approved a new strength of a drug for HIV made by Johnson & Johnson, the drug maker said.

    J&J subsidiary Janssen Therapeutics announced the approval of an 800-mg formulation of Prezista (darunavir) as a once-daily treatment for HIV. The drug is designed to be taken with food at the same time as ritonavir and in combination with other HIV drugs.

  • FDA approves Watson PAH drug

    PARSIPPANY, N.J. — The Food and Drug Administration has approved a generic drug for pulmonary arterial hypertension made by Watson Pharmaceuticals, the drug maker said Monday.

    Watson said the FDA approved its sildenafil tablets in the 20 mg strength through a subsidiary. Watson said it would launch the drug "in the near future."

    The drug is a generic version of Pfizer's Revatio tablets, which had sales of about $339 million during the 12-month period ended in September, according to IMS Health.

  • 30 Watt introduces Connect-A-Cord PrankPack

    MINNEAPOLIS – The pranksters at 30 Watt have introduced a new way to fool family and friends this holiday season, with a fake new product that supposedly solves the issue of hard-to-reach electrical devices — Connect-A-Cord, 50 one-foot sections of cord — the company announced on Monday.

    With 50 separate cords, Connect-A-Cord is a new solution to tangled cords, the product's box claims. The product's packaging also boasts that it comes with an optional contractor case for tangle-free storage.

  • Links Medical launches diabetes meters for pets

    IRVINE, Calif. – Links Medical Products Animal Health Group on Thursday announced the introduction of their new Pet Gluco blood-glucose monitoring system for dogs and cats.

  • Panasonic introduces small toothbrush for women

    SECAUCUS, N.J. — Panasonic has introduced a toothbrush to its line of compact personal care products for women, the company said Friday.

    Panasonic announced the introduction of the EW-DS90 series of battery-operated compact toothbrushes, adding it to its compact body shavers, facial hair trimmers and heated eyelash curlers.

X
This ad will auto-close in 10 seconds